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Abstract: Allosteric regulation promises to open up new therapeutic 
avenues by increasing drug specificity at G protein-coupled 
receptors (GPCRs). However, drug discovery efforts are at present 
hampered by the inability to precisely control the allosteric site. Here, 
we describe the design, synthesis and testing of PhotoETP, a light-
activated positive allosteric modulator of the glucagon-like peptide-1 
receptor (GLP-1R), a class B GPCR involved in the maintenance of 
glucose homeostasis in humans. PhotoETP potentiates Ca2+, cAMP 
and insulin responses to glucagon-like peptide-1 and its metabolites 
following illumination of cells with blue light. Thus, PhotoETP 
provides a blueprint for the production of small molecule class B 
GPCR allosteric photoswitches, and may represent a useful tool for 
understanding positive cooperativity at the GLP-1R. 
The incretin hormone glucagon-like peptide 1 (GLP-1) is 
released from enteroendocrine L-cells in the intestine,[1] from 
where it binds cognate receptors to promote pancreatic beta cell 
survival, insulin release and weight loss.[2] For these reasons, 
incretin-mimetics based on GLP-1 have become widely-
prescribed drugs for the restoration of normal glucose levels 
during type 2 diabetes (T2D),[3] a socioeconomically costly 
syndrome affecting almost 400 million individuals worldwide.[4] 
The glucagon-like peptide 1 receptor (GLP-1R) is a class B 
GPCR primarily coupled to adenylate cyclase activity and 3'-5'-
cyclic adenosine monophosphate (cAMP) accumulation,[5] as 
well as intracellular Ca2+ fluxes.[6] Recently, an allosteric site has 
been described for this receptor, allowing the fine modulation of 
orthosteric ligand binding.[7] Thus, the ligand-dependent 
allosteric activator 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-
(trifluoromethyl)pyrimidine (BETP) potentiates Ca2+ mobilization 
in response to GLP-1(7-36)NH2,[7-8] the active amidated form of 
GLP-1. By contrast, BETP amplifies cAMP generation in 
response to GLP-1(9-36)NH2,[7-8] a metabolite and weak partial 
GLP-1R agonist. Such interactions are therapeutically-desirable, 
since drugs that target the GLP-1R allosteric site may improve 
receptor specificity, thereby reducing side effects.[7-9] However, 
their investigation is at present hindered by a lack of specific 
research tools for the fine control of allosterism and receptor 
movement. Photopharmacology is well-suited to this task, since 
it relies on the properties of light to precisely deliver drug activity 
in space and time.[10] 
Herein, we describe the development and testing of 
PhotoETP, a light-activated positive allosteric modulator that 
allows optical control of GLP-1R signaling and insulin secretion 
using blue light (Figure 1A). 
Figure 1. Logic and synthesis of PhotoETP. a) An azobenzene is installed on 
the positive allosteric modulator, BETP, to produce PhotoETP. This allows 
Ca2+ and cAMP responses to GLP-1 and its inactive metabolites to be 
reversibly potentiated following illumination with UV or blue light. b) Six-step 
synthetic pathway for production of PhotoETP. c) Crystallization of PhotoETP 
to its methoxy counterpart (7) using MeOH. d) Crystal structures for 
PhotoETP congener 7 (CDCC: 1420305) and its precursor bisaryl thioether 3 
(CDCC: 1420306). 
We set out to confer photoswitching on the GLP-1R 
allosteric site by subjecting BETP to our azologization strategy[11] 
(Figure 1B) (Figure S1). By coupling commercially available 
chloropyrimidine 1 and boronic acid 2 under Suzuki-Miyaura 
conditions, bisaryl thioether 3 was obtained in 95%. After 
oxidizing the sulfur atom with mCPBA to its sulfone counterpart 
4 in 90%, it was exchanged in an aromatic substitution with -
mercaptoethanol to give ethyl thioether 5 in 55%. Subsequent 
oxidation with one equivalent of mCPBA gave access to 
sulfoxide 6 (96%), which was deprotected with TFA before 
undergoing Mills reaction with nitrosobenzene to produce 
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PhotoETP in 54% over two steps. Attempts to crystallize 
PhotoETP from MeOH yielded compound 7, providing further 
evidence for the electrophilicity of PhotoETP and its congeners 
(Figure 1C). Crystals suitable for x-ray crystallography were 
obtained for both 3 and 7 (Figure 1D).  
The UV/Vis spectrum of PhotoETP under illumination with λ 
= 440 nm (trans, blue) and λ = 330 nm (cis, gray) demonstrated 
the presence of wavelength-dependent switching (Figure 2A), as 
expected for a meta-azobenzene system (Figure 2B). 
Photoswitching could be repeated over several cycles with 
reasonably fast kinetics (τcis = 204.2 ± 7.3 sec; τtrans = 54.5 ± 2.9 
sec) and without obvious fatigue (Figure 2C), and the cis- and 
trans-isomers were separated by LC-MS analysis (Figure 2D). 
Together, these features of PhotoETP provided a basis for the 
allosteric photocontrol of GLP-1R activity.  
Figure 2. Characterization of PhotoETP. a) Isomerization of PhotoETP 
between its trans- and cis- states using blue light or UV, respectively. b) UV-
Vis spectra of PhotoETP in DMSO following illumination with λ = 440 nm 
(blue), λ = 330 nm (grey) or under dark conditions (black). c) Robust 
photoswitching between cis- and trans-PhotoETP induced with λ = 440 nm 
and λ = 330 nm, respectively. d) LC-MS trace of PhotoETP in the dark (black) 
and after UV light (λ = 350 nm) exposure (gray). 
We next examined whether PhotoETP was able to yield 
optical control over GLP-1(9-36)NH2-induced cAMP generation. 
Similarly to BETP, trans-PhotoETP potentiated cAMP rises in 
response to GLP-1(9-36)NH2 (EC50 (trans-PhotoETP) = 163.3 
nM) (EC50 (BETP) = 99.5 nM). Importantly, this activity could be 
switched off using UV illumination to induce cis-isomer formation 
(Figure 3A) (unable to calculate EC50). The extent of 
photoswitching is similar to that recently reported for an 
allosteric modulator of the metabotropic glutamate receptor 
mGluR5, a class C GPCR.[12] Effects of PhotoETP on cell 
viability were determined in islets using necrosis and apoptosis 
assays in the dark. At the concentration used throughout the 
present study, PhotoETP did not induce significant necrosis 
(Figure 3B) or apoptosis (Figure 3C), as measured using 
propidium iodide incorporation and terminal deoxynucleotidyl 
transferase dUTP nick end labelling (TUNEL), respectively. By 
contrast, treatment with staurosporine or thapsigargin positive 
controls resulted in large increases in necrotic and apoptotic 
indices (Figure 3B,C). Furthermore, levels of cleaved caspase-3, 
an enzyme involved in the proteolytic cleavage of critical 
intracellular effectors including poly (ADP-ribose) polymerase, 
were unaffected during incubation with PhotoETP (Figure S2). 
Figure 3. Optical control of cAMP and Ca2+ signals. a) Illumination with λ = 
440 nm, but not λ = 350 nm (UV), optically modulates GLP-1(9-36)NH2-
induced cAMP generation in CHO-GLP-1R cells (n = 4 repeats). b) Incubation 
of MIN6 beta cells with PhotoETP for 3 hr does not alter cell viability (n = 8 
repeats) (+ve = positive control; staurosporine or thapsigargin). c) As for b) but 
apoptosis (n = 3 repeats). d-g) Illumination with λ = 440 nm, but not λ = 350 
nm, modulates GLP-1(7-36)NH2-induced Ca2+ rises in intact PhotoETP-
treated islets (n = 9 recordings from 3 animals). h-j) As for a-d, but in MIN6 
beta cells (n = 8 repeats) (RFU = relative fluorescence units; AUC = area 
under the curve). In all cases, GLP-1(7-36)NH2 was co-applied at 10 nM in the 
presence of 8-11 (islets) or 17 (MIN6) mM D-glucose. PhotoETP and BETP 
were applied at 50 µM. NS, non-significant or **P<0.01 versus cis-PhotoETP 
or DMSO; one-way ANOVA. Values represent mean ± s.e.m. Scale bar, 75 
µm. 
Next, photoswitching of intracellular Ca2+ dynamics was 
assessed using PhotoETP directly in beta cells residing within 
intact islets of Langerhans. Whereas cis-PhotoETP (λ = 350 
nm) was largely without effect, the trans-isomer (λ = 440 nm) 
potentiated GLP-1(7-36)NH2-induced Ca2+ rises (Figure 3D-G), 
as for cAMP. The latter could be abolished using either low 
glucose (Figure S3A,B) or the specific GLP-1R antagonist, 
exendin 9-39 (Figure S3C,D). In all cases, results in islets were 
replicated using MIN6 beta cells subjected to high-throughput 
Ca2+ screens (Figure 3H-J). Using batch-incubated islets, trans-
PhotoETP potently amplified GLP-1(9-36)NH2-induced insulin 
secretion (Figure 4A), whereas cis-PhotoETP was less effective 
as an allosteric modulator (Figure 4A). By contrast, BETP, cis-
PhotoETP and trans-PhotoETP all augmented insulin secretion 
in response to GLP-1(7-36)NH2 by almost 2-fold (Figure 4B), 
with no evidence of photocontrol.  
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Figure 4. Optical control of insulin secretion. a) trans-PhotoETP is more 
effective than cis-PhotoETP at potentiating GLP-1(9-36)NH2-induced insulin 
secretion. b) trans-PhotoETP and cis-PhotoETP similarly potentiate GLP-1(7-
36)NH2-induced insulin secretion. In all cases, GLP-1(7-36)NH2 was co-
applied at 10 nM in the presence of 11 mM D-glucose. PhotoETP and BETP 
were applied at 50 µM. NS, non-significant or *P<0.05 versus cis-PhotoETP 
or BETP; one-way ANOVA. Values represent mean ± s.e.m.  
PhotoETP was almost 20% cis-enriched under benchtop 
conditions (1H-NMR; see SI), whereas the UV-Vis spectra 
revealed a more pronounced π-π* band in the dark (see Figure 
2B). This finding can further be explained by consulting a model 
of the glucagon receptor mutant F345C bound to BETP, where a 
twisted conformation of the benzylether is found, being the 
lowest energy state.[7] Such a conformation may also be adopted 
by cis-PhotoETP due to its higher affinity for covalent binding. 
However, in contrast to BETP, which can reorganize its 
molecular shape in response to orthosteric ligand binding, 
PhotoETP would remain trapped in its cis-state until illumination 
to induce trans-isomerization. Although the exact isomer ratio at 
the receptor is difficult to determine empirically, such properties 
may nonetheless afford fine control over photoswitching, with 
dark, 440 nm and 350 nm leading to graded Ca2+ responses 
(Figure S4). Further studies using rigid E- and Z-stilbene 
bioisosteres of PhotoETP will be required to better delineate the 
mechanisms involved. 
The data presented here outline a straightforward synthetic 
strategy for the production of a blue light-activated positive 
allosteric modulator, which enables photocontrol of GLP-1R 
activity via a feedforward loop encompassing the orthosteric site 
(Figure 1A). Although similar ‘alloswitches’ have been described 
for ionotropic and metabotropic mGluRs,[12-13] this is the first 
demonstration of their use in a therapeutically-relevant class B 
GPCR. Using a combination of Ca2+, cAMP and insulin assays in 
CHO-GLP-1R and MIN6 cells, as well as islets of Langerhans, 
we are able to show that PhotoETP allows photoswitching of 
responses to GLP-1(7-36)NH2 and its less active breakdown 
product, GLP-1(9-36)NH2, with similar potency to native BETP. 
Notably, PhotoETP displays unusual behavior in cells, where it 
possesses an enriched cis-content when interacting with its 
target in the dark. Indeed, the more active trans-isomer has to 
be photochemically induced by irradiation with blue light. Due to 
these properties, PhotoETP, together with the recently 
described signal-biased GLP-1R photoswitch LirAzo,[14] may 
allow the precise dissection of allosteric-orthosteric 
cooperativity, molecular movement and binding.  
Both BETP and PhotoETP were more effective at 
potentiating GLP-1(9-36)NH2- compared to GLP-1(7-36)NH2-
induced insulin secretion. This suggests that cAMP rather than 
Ca2+ is the primary driver of the ‘incretin effect’, and is consistent 
with previous results obtained using LirAzo.[14] Intriguingly, 
optical control of insulin release could only be observed in GLP-
1(9-36)NH2 and PhotoETP-treated islets, where blue light 
provoked a two-fold higher response than UV illumination. 
Although the exact reasons for this remain unknown, it may 
reflect the inability to detect relatively small isomer-induced 
differences in intracellular Ca2+ versus cAMP concentration at 
the level of secretion in islets.  
BETP was susceptible to UV-A- but not white light-induced 
reactions, thus acting as a poor control for photoswitching 
purposes (see SI for a description of the results) (Figure S5-S8). 
In contrast, PhotoETP was remarkably robust. This protective 
effect stems from the azobenzene unit, which preferentially 
harvests UV-A photons with its π-π*-band to undergo 
isomerization. In other words, by installing an azobenzene 
moiety onto BETP, side reactions can be quenched and the 
resulting molecule stabilized. Nevertheless, the UV-A-induced 
rearrangement of BETP to its sulfenic ester counterpart via a 
Meisenheimer complex, and the accompanying transformation, 
is in itself an interesting finding (Fig. S5,S6). Although related 
rearrangements of sulfoxides have been reported,[15] sulfenic 
esters have not been isolated as products due to the low (UV-C) 
wavelengths used in these experiments. Such rearrangements 
are relevant for drug activity, as best exemplified by acid-
activation of the irreversible proton pump inhibitor omeprazole 
(Prilosec).[16] 
In summary, we showcase PhotoETP, a light-activated 
modulator for the allosteric optical control of GLP-1R function, 
and highlight the requirement to run parallel control experiments 
with benchmark drugs in photopharmacology. PhotoETP, or 
optimized derivatives thereof, may be useful in drug discovery 
programs aimed at unraveling the complexity of allosterism and 
class B GPCR signaling. 
Experimental Section  
Experimental details including synthesis, spectroscopic and 
spectrometric characterization, and biology can be found in the 
Supporting Information. 
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